49627-22-7 ({5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-y l}acetic acid,{5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1h-inden-3-y L}acetic Acid)

{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-y l}acetic acid;

{5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1h-inden-3-y L}acetic Acid;S-Sulindac Sulfoxide;UNII-184SNS8VUH component MLKXDPUZXIRXEP-WXKFDZDZSA-N;(S)-Sulindac;(1Z)-5-Fluoro-2-methyl-1-[[4-[(S)-methylsulfinyl]phenyl]methylene]-1H-indene-3-acetic Acid;UNII-P969C405OM;5-fluoro-2-methyl-1-(p-methylsulfinylbenzylidene)-3-indenyl acetic acid;S-Sulindac Sulfoxide; UNII-184SNS8VUH component MLKXDPUZXIRXEP-WXKFDZDZSA-N; (S)-Sulindac; (1Z)-5-Fluoro-2-methyl-1-[[4-[(S)-methylsulfinyl]phenyl]methylene]-1H-indene-3-acetic Acid; UNII-P969C405OM; 5-fluoro-2-methyl-1-(p-methylsulfinylbenzylidene)-3-indenyl acetic acid;;CHEMBL1376;1H-Indene-3-acetic acid, 5-fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-, (E)-;Prestwick_456;BDBM54707;2-[(3E)-6-fluoranyl-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]ethanoic acid;Sulindac, trans-;UNII-5NVO8803F9;DTXSID90860554;HMS1568O07;BBL010958;(1Z)-5-Fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-1H-indene-3-acetic acid;EINECS 258-873-0;UNM-0000306136;(E)-(5-FLUORO-2-METHYL-1-(4-(METHYLSULFINYL)BENZYLIDENE)-1H-INDEN-3-YL)ACETIC ACID;SULINDAC, TRANS-(+/-)-;32004-68-5;R-Sulindac Sulfoxide;STK802068;AKOS004119989;1H-INDENE-3-ACETIC ACID, 5-FLUORO-2-METHYL-1-((4-(METHYLSULFINYL)PHENYL)METHYLENE)-, (1E)-;BRD-A03427350-001-01-3;Q27262612;cid_1548885;trans-Sulindac;MLS001304027;2-(5-Fluoro-2-methyl-1-(4-(methylsulfinyl)benzylidene)-1H-inden-3-yl)acetic acid;38194-50-2;(Z)-5-Fluoro-2-methyl-1-[p-(methylsulfinyl)benzylidene]indene-3-acetic acid;Sulindac sulfoxide;SULINDAC RELATED COMPOUND A (20 MG) (TRANS-SULINDAC);MLS002207124;(E)-(1)-5-Fluoro-2-methyl-1-((4-(methylsulphinyl)phenyl)methylene)-1H-indene-3-acetic acid;HMS2089J04;53933-60-1;HMS2233D04;49627-22-7;5NVO8803F9;SMR000043852;2-[(3E)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]-1-indenyl]acetic acid;((1Z)-5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl)acetic acid;{(1E)-5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid;NCGC00188951-01;Prestwick2_000073;2-[(3E)-6-fluoro-2-methyl-3-(4-methylsulfinylbenzylidene)inden-1-yl]acetic acid;NS00088652;MK 231;MFCD00599589;Reumyl;SULINDAC IMPURITY A [EP IMPURITY];NS00096946;[(1E)-5-fluoro-2-methyl-1-{[4-(methylsulfinyl)phenyl]methylidene}-1H-inden-3-yl]acetic acid;SCHEMBL755984;AC-4550;cis-5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benZylidene]indene-3-acetic acid;(E)-2-(5-fluoro-2-methyl-1-(4-(methylsulfinyl)benzylidene)-1H-inden-3-yl)acetic acid;2-[(3E)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid;1H-Indene-3-aceticacid, 5-fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-, (1Z)-;Sulindac (Clinoril);

MLKXDPUZXIRXEP-RQZCQDPDSA-N

1S/C20H17FO3S/c1-12-17(9-13-3-6-15(7-4-13)25(2)24)16-8-5-14(21)10-19(16)18(12)11-20(22)23/h3-10H,11H2,1-2H3,(H,22,23)/b17-9+

S(C)(C1C=CC(=CC=1)/C=C1/C2C=CC(=CC=2C(CC(=O)O)=C/1C)F)=O